Literature DB >> 17716614

ABAP: antibody-based assay for peptidylarginine deiminase activity.

Albert J W Zendman1, Reinout Raijmakers, Suzanne Nijenhuis, Erik R Vossenaar, Marloes van den Tillaart, Renato G S Chirivi, Jos M H Raats, Walther J van Venrooij, Jan W Drijfhout, Ger J M Pruijn.   

Abstract

Members of the family of peptidylarginine deiminases (PADs, EC 3.5.3.15) catalyze the posttranslational modification of peptidylarginine into peptidylcitrulline. Citrulline-containing epitopes have been shown to be major and specific targets of autoantibodies produced by rheumatoid arthritis patients. Recently, the citrullination of histone proteins by PAD enzyme was reported to influence gene expression levels. These findings greatly increase the interest in the PAD enzymes and their activities. A few procedures to monitor PAD activity in biological samples have been described previously. However, these assays either have low sensitivity or are rather laborious. Here we describe a reliable and reproducible method for the determination of PAD activity in both purified and crude samples. The method is based on the quantification of PAD-dependent citrullination of peptides, immobilized in microtiter plates, using antibodies that are exclusively reactive with the reaction product(s). Our results demonstrate that this antibody-based assay for PAD activity, called ABAP, is very sensitive and can be applied to monitor PAD activity in biological samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716614     DOI: 10.1016/j.ab.2007.07.009

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  Uncovering a Shared Epitope-Activated Protein Citrullination Pathway.

Authors:  Vincent van Drongelen; Wahida H Ali; Joseph Holoshitz
Journal:  J Immunol       Date:  2020-06-26       Impact factor: 5.422

2.  Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning.

Authors:  Martha Adriana Badillo-Soto; Mayra Rodríguez-Rodríguez; María Elena Pérez-Pérez; Leonel Daza-Benitez; Juan José Bollain-Y-Goytia; Miguel Angel Carrillo-Jiménez; Esperanza Avalos-Díaz; Rafael Herrera-Esparza
Journal:  Eur J Rheumatol       Date:  2016-02-01

3.  Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.

Authors:  Bryan Knuckley; Corey P Causey; Justin E Jones; Monica Bhatia; Christina J Dreyton; Tanesha C Osborne; Hidenari Takahara; Paul R Thompson
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

4.  Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.

Authors:  Nicoletta Sorvillo; Daniella M Mizurini; Carmen Coxon; Kimberly Martinod; Ronak Tilvawala; Deya Cherpokova; Ari J Salinger; Robert J Seward; Caleb Staudinger; Eranthie Weerapana; Nathan I Shapiro; Catherine E Costello; Paul R Thompson; Denisa D Wagner
Journal:  Circ Res       Date:  2019-06-28       Impact factor: 17.367

Review 5.  Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination.

Authors:  Sanne M M Hensen; Ger J M Pruijn
Journal:  Mol Cell Proteomics       Date:  2013-12-02       Impact factor: 5.911

6.  Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.

Authors:  Bryan Knuckley; Yuan Luo; Paul R Thompson
Journal:  Bioorg Med Chem       Date:  2007-10-13       Impact factor: 3.641

7.  Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance.

Authors:  Joyce J B C van Beers; Reinout Raijmakers; Lou-Ella Alexander; Judith Stammen-Vogelzangs; Angelique M C Lokate; Albert J R Heck; Richard B M Schasfoort; Ger J M Pruijn
Journal:  Arthritis Res Ther       Date:  2010-12-23       Impact factor: 5.156

8.  Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen.

Authors:  Dres Damgaard; Ladislav Senolt; Michael Friberg Nielsen; Ger J Pruijn; Claus H Nielsen
Journal:  Arthritis Res Ther       Date:  2014-12-05       Impact factor: 5.156

9.  Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation.

Authors:  Paul Proost; Tamara Loos; Anneleen Mortier; Evemie Schutyser; Mieke Gouwy; Samuel Noppen; Chris Dillen; Isabelle Ronsse; René Conings; Sofie Struyf; Ghislain Opdenakker; Prabhat C Maudgal; Jo Van Damme
Journal:  J Exp Med       Date:  2008-08-18       Impact factor: 14.307

10.  Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss.

Authors:  Akilan Krishnamurthy; Vijay Joshua; Aase Haj Hensvold; Tao Jin; Meng Sun; Nancy Vivar; A Jimmy Ytterberg; Marianne Engström; Cátia Fernandes-Cerqueira; Khaled Amara; Malin Magnusson; Gustaf Wigerblad; Jungo Kato; Juan Miguel Jiménez-Andrade; Kerry Tyson; Stephen Rapecki; Karin Lundberg; Sergiu-Bogdan Catrina; Per-Johan Jakobsson; Camilla Svensson; Vivianne Malmström; Lars Klareskog; Heidi Wähämaa; Anca I Catrina
Journal:  Ann Rheum Dis       Date:  2015-11-26       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.